Showing posts with label Vemurafenib. Show all posts
Showing posts with label Vemurafenib. Show all posts

Thursday, August 23, 2012

GW786034 -- A Deep Study On What Works And Precisely what Doesn't

The main examination of effi cacy was based mostly on the assessments of response and condition progression for each patient by the independent response evaluation panel, members of which had been masked to therapy assignment. Response criteria and progression had been assessed according to the National Cancer Institute PARP Inhibitors Operating Groups 1996 tips for CLL, criteria for condition progression had been specifi ed in the study protocol and had been in accordance with these tips.